公开(公告)号：US08865873B2

公开(公告)日：2014-10-21

申请号：US12724282

申请日：2010-03-15

Applicant: Bin Liu ,  James D. Marks

Inventor： Bin Liu ,  James D. Marks

IPC: C07K16/30 ,  A61K51/10 ,  C07K16/28

CPC classification number: C07K16/3069 ,  A61K51/1072 ,  A61K2039/505 ,  C07K16/005 ,  C07K16/18 ,  C07K16/2803 ,  C07K16/30 ,  C07K2317/21 ,  C07K2317/56 ,  C07K2317/565 ,  C07K2317/569 ,  C07K2317/622 ,  C07K2317/77 ,  G01N33/5044 ,  G01N33/57434 ,  G01N33/6845 ,  G01N33/6854

Abstract: This invention provides a method that allows selection of antibodies against cells (e.g., tumor cells) in situ using laser capture microdissection. By restricting antibody selection to binders of internalizing epitopes, a panel of phage antibodies was generated that targets clinically represented prostate cancer antigens.

Abstract translation: 本发明提供允许使用激光捕获显微切割原位选择针对细胞（例如肿瘤细胞）的抗体的方法。 通过将抗体选择限于内化表位的结合物，产生一组靶向临床表现的前列腺癌抗原的噬菌体抗体。

公开(公告)号：US20090010841A1

公开(公告)日：2009-01-08

申请号：US11972130

申请日：2008-01-10

Applicant: Bin Liu ,  James D. Marks

Inventor： Bin Liu ,  James D. Marks

IPC: C07K16/30 ,  C07K16/46 ,  A61K39/395 ,  A61K51/10 ,  C12N15/13 ,  C12N5/10 ,  G01N33/574 ,  C12N5/06 ,  A61P35/00

CPC classification number: C07K16/3069 ,  A61K2039/505 ,  C07K2317/622 ,  C07K2317/73 ,  C07K2317/77

Abstract: This invention provides novel prostate cancer specific internalizing human antibodies. The antibodies are useful by themselves to prevent growth and/or proliferation of prostate cancer cells. The antibodies can also be formulated as chimeric molecules to direct an effector (e.g. a cytotoxin, an imaging reagent, a drug, etc.) to a prostate tumor site.

Abstract translation: 本发明提供了新型前列腺癌特异性内化人抗体。 抗体本身有用于预防前列腺癌细胞的生长和/或增殖。 抗体还可以配制成嵌合分子以将效应物（例如细胞毒素，成像试剂，药物等）引导至前列腺肿瘤部位。

公开(公告)号：US09145462B2

公开(公告)日：2015-09-29

申请号：US13172759

申请日：2011-06-29

Applicant: Bin Liu ,  James D. Marks ,  Xiaodong Zhu ,  Scott Bidlingmaier

Inventor： Bin Liu ,  James D. Marks ,  Xiaodong Zhu ,  Scott Bidlingmaier

IPC: A61K39/395 ,  C07K16/28 ,  C07K16/30 ,  C12N5/095 ,  G01N33/574

CPC classification number: C07K16/18 ,  A61K47/6843 ,  A61K51/1045 ,  C07K16/2896 ,  C07K16/3053 ,  C07K2317/21 ,  C07K2317/54 ,  C07K2317/55 ,  C07K2317/622 ,  C07K2317/73 ,  C07K2317/77 ,  C07K2317/92 ,  C12N5/0695 ,  G01N33/57407

Abstract: The present disclosure is generally related to antibodies that bind specifically to glioblastoma multiforme (GBM) cells. In particular, the present disclosure provides compositions comprising human single chain or full-length antibodies that bind tumor cells. Additionally the present disclosure provides methods of using the anti-GBM antibodies.

Abstract translation: 本公开通常涉及特异性结合多形性胶质母细胞瘤（GBM）细胞的抗体。 特别地，本公开提供了包含结合肿瘤细胞的人单链或全长抗体的组合物。 另外，本公开提供了使用抗GBM抗体的方法。

公开(公告)号：US07582736B2

公开(公告)日：2009-09-01

申请号：US11972130

申请日：2008-01-10

Applicant: Bin Liu ,  James D. Marks

Inventor： Bin Liu ,  James D. Marks

IPC: C12P21/08

CPC classification number: C07K16/3069 ,  A61K2039/505 ,  C07K2317/622 ,  C07K2317/73 ,  C07K2317/77

Abstract: This invention provides novel prostate cancer specific internalizing human antibodies. The antibodies are useful by themselves to prevent growth and/or proliferation of prostate cancer cells. The antibodies can also be formulated as chimeric molecules to direct an effector (e.g. a cytotoxin, an imaging reagent, a drug, etc.) to a prostate tumor site.

Abstract translation: 本发明提供了新型前列腺癌特异性内化人抗体。 抗体本身可用于预防前列腺癌细胞的生长和/或增殖。 抗体还可以配制成嵌合分子以将效应物（例如细胞毒素，成像试剂，药物等）引导至前列腺肿瘤部位。

公开(公告)号：US07335744B2

公开(公告)日：2008-02-26

申请号：US11021438

申请日：2004-12-21

Applicant: Bin Liu ,  James D. Marks

Inventor： Bin Liu ,  James D. Marks

IPC: C12P21/08

CPC classification number: C07K16/3069 ,  A61K2039/505 ,  C07K2317/622 ,  C07K2317/73 ,  C07K2317/77

Abstract: This invention provides novel prostate cancer specific internalizing human antibodies. The antibodies are useful by themselves to prevent growth and/or proliferation of prostate cancer cells. The antibodies can also be formulated as chimeric molecules to direct an effector (e.g. a cytotoxin, an imaging reagent, a drug, etc.) to a prostate tumor site.

Abstract translation: 本发明提供了新型前列腺癌特异性内化人抗体。 抗体本身可用于预防前列腺癌细胞的生长和/或增殖。 抗体还可以配制成嵌合分子以将效应物（例如细胞毒素，成像试剂，药物等）引导至前列腺肿瘤部位。

公开(公告)号：USD1053603S1

公开(公告)日：2024-12-10

申请号：US29871577

申请日：2023-02-23

Applicant: Bin Liu

Designer： Bin Liu

公开(公告)号：USD963755S1

公开(公告)日：2022-09-13

申请号：US29817319

申请日：2021-11-30

Applicant: Bin Liu

Designer： Bin Liu

公开(公告)号：USD951671S1

公开(公告)日：2022-05-17

申请号：US29787621

申请日：2021-06-08

Applicant: Bin Liu

Designer： Bin Liu

公开(公告)号：USD916598S1

公开(公告)日：2021-04-20

申请号：US29706597

申请日：2019-09-20

Applicant: Bin Liu

Designer： Bin Liu

公开(公告)号：US10753941B2

公开(公告)日：2020-08-25

申请号：US14342074

申请日：2012-09-03

Applicant: Benzhong Tang ,  Wei Qin ,  Jianzhao Liu ,  Sijie Chen ,  Tsz Kin Kwok ,  Bin Liu ,  Kai Li ,  Dan Ding ,  Haibin Shi ,  Jun Long Geng ,  Jingzhi Sun ,  Anjun Qin ,  Qiuli Zhao

Inventor： Benzhong Tang ,  Wei Qin ,  Jianzhao Liu ,  Sijie Chen ,  Tsz Kin Kwok ,  Bin Liu ,  Kai Li ,  Dan Ding ,  Haibin Shi ,  Jun Long Geng ,  Jingzhi Sun ,  Anjun Qin ,  Qiuli Zhao

IPC: A61B5/00 ,  A61B8/00 ,  A61B10/00 ,  G01N33/58 ,  A61K49/00 ,  C09K11/06 ,  C12Q1/37 ,  G01N33/574

Abstract: The development of fluorescent bioprobes comprising organic fluorescent compounds that exhibit aggregation induced emission (AIE) properties, methods of producing the same, and their practical applications for in vitro and in vivo bioimaging.